Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis
Authors
Keywords
MicroRNAs, Fatty liver, Biomarkers, Obesity, Steatosis, Diagnostic medicine, Fibrosis, Biopsy
Journal
PLoS One
Volume 10, Issue 11, Pages e0142661
Publisher
Public Library of Science (PLoS)
Online
2015-11-14
DOI
10.1371/journal.pone.0142661
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells
- (2015) J. Zhang et al. CANCER RESEARCH
- Circulating microRNAs: Emerging Biomarkers of Liver Disease
- (2015) Marco Arrese et al. SEMINARS IN LIVER DISEASE
- MicroRNAs in Fatty Liver Disease
- (2015) Cyril Sobolewski et al. SEMINARS IN LIVER DISEASE
- Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases
- (2014) Christoph Roderburg et al. LIVER INTERNATIONAL
- Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma
- (2014) Burcu Gurer Giray et al. MOLECULAR BIOLOGY REPORTS
- Determination of 14 Circulating microRNAs in Swedes and Iraqis with and without Diabetes Mellitus Type 2
- (2014) Xiao Wang et al. PLoS One
- A Critical Evaluation of microRNA Biomarkers in Non-Neoplastic Disease
- (2014) Baqer A. Haider et al. PLoS One
- A Pilot Study of Serum MicroRNAs Panel as Potential Biomarkers for Diagnosis of Nonalcoholic Fatty Liver Disease
- (2014) Youwen Tan et al. PLoS One
- MicroRNAs in Nonalcoholic Fatty Liver Disease: Novel Biomarkers and Prognostic Tools during the Transition from Steatosis to Hepatocarcinoma
- (2014) Manuele Gori et al. Biomed Research International
- Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver
- (2013) Hiroya Yamada et al. CLINICA CHIMICA ACTA
- Epidemiology and Natural History of Patients with NAFLD
- (2013) Neeraj Bhala et al. CURRENT PHARMACEUTICAL DESIGN
- Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2013) Paul Angulo et al. GASTROENTEROLOGY
- Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease
- (2013) Kenneth Cusi et al. JOURNAL OF HEPATOLOGY
- Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease
- (2013) Hisamitsu Miyaaki et al. LIVER INTERNATIONAL
- Circulating MicroRNAs and Aerobic Fitness – The HUNT-Study
- (2013) Anja Bye et al. PLoS One
- Kinetics of miR-122 Expression in the Liver during Acute HCV Infection
- (2013) Youkyung Choi et al. PLoS One
- HCV-Induced miR-21 Contributes to Evasion of Host Immune System by Targeting MyD88 and IRAK1
- (2013) Yanni Chen et al. PLoS Pathogens
- Nonalcoholic Fatty Liver Disease/Steatohepatitis: Epidemiology, Pathogenesis, Clinical Presentation and Treatment
- (2012) Sandra Milic et al. DIGESTIVE DISEASES
- Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases
- (2012) Shashi Bala et al. HEPATOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Circulating MicroRNA-122 signature in nonalcoholic fatty liver disease and cardiovascular disease: A new endocrine system in metabolic syndrome
- (2012) Carlos J. Pirola et al. HEPATOLOGY
- miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression
- (2012) Jiang Li et al. JOURNAL OF HEPATOLOGY
- Small RNAs have a large impact
- (2012) Matthew Weiland et al. RNA Biology
- Role of microRNAs in hepatitis B virus replication and pathogenesis
- (2011) Wan-Hsin Liu et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Identification of Suitable Reference Genes for qPCR Analysis of Serum microRNA in Gastric Cancer Patients
- (2011) Jianning Song et al. DIGESTIVE DISEASES AND SCIENCES
- Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans
- (2011) Jussi Pihlajamäki et al. JOURNAL OF HEPATOLOGY
- MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4
- (2011) K Schramedei et al. ONCOGENE
- Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease
- (2011) Silvia Cermelli et al. PLoS One
- Haemolysis during Sample Preparation Alters microRNA Content of Plasma
- (2011) Michaela B. Kirschner et al. PLoS One
- Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma
- (2011) Verena Bihrer et al. PLoS One
- Normalization strategies for microRNA profiling experiments: a ‘normal’ way to a hidden layer of complexity?
- (2010) Swanhild U. Meyer et al. BIOTECHNOLOGY LETTERS
- Plasma MicroRNA-122 as a Biomarker for Viral-, Alcohol-, and Chemical-Related Hepatic Diseases
- (2010) Y. Zhang et al. CLINICAL CHEMISTRY
- Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings
- (2010) Elizabeth M. Brunt et al. HEPATOLOGY
- Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
- (2009) Curtis K. Argo et al. JOURNAL OF HEPATOLOGY
- Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties
- (2009) C Coulouarn et al. ONCOGENE
- Circulating microRNAs, potential biomarkers for drug-induced liver injury
- (2009) K. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel and universal method for microRNA RT-qPCR data normalization
- (2009) Pieter Mestdagh et al. GENOME BIOLOGY
- Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
- (2008) S A Harrison et al. GUT
- Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression
- (2008) Onpan Cheung et al. HEPATOLOGY
- Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes
- (2008) Manlio Vinciguerra et al. HEPATOLOGY
- A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)
- (2008) Zobair M. Younossi et al. OBESITY SURGERY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started